Gelteq (GELS) Liabilities and Shareholders Equity (2023 - 2025)
Gelteq's (GELS) quarterly Liabilities and Shareholders Equity came in at $13.2 million in Q4 2025, down 19.55% year-on-year from $16.4 million in Q4 2024, and down 3.92% quarter-over-quarter from $13.8 million in Q2 2025.
Gelteq (GELS) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends
Gelteq's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $13.2 million for Q4 2025.
- On a quarterly basis, Liabilities and Shareholders Equity fell 19.55% year-over-year to $13.2 million in Q4 2025; TTM through Dec 2025 was $57.1 million, a 26.44% increase from a year earlier, with the FY2025 full-year figure at $13.8 million, up 0.54% from the prior year.
- Liabilities and Shareholders Equity slipped to $13.2 million in Q4 2025 per GELS's latest filing, from $13.8 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $16.4 million in Q4 2024 and bottomed at $13.2 million in Q4 2025.
- The 3-year median for Liabilities and Shareholders Equity is $13.8 million (2025), against an average of $14.4 million.
- Biggest YoY gain for Liabilities and Shareholders Equity was 0.54% in 2025; the steepest drop was 19.55% in 2025.
- Year by year, Liabilities and Shareholders Equity stood at $15.0 million in 2023, then gained by 9.24% to $16.4 million in 2024, then fell by 19.55% to $13.2 million in 2025.
- Per Business Quant, the three latest GELS Liabilities and Shareholders Equity figures stand at $13.2 million (Q4 2025), $13.8 million (Q2 2025), and $16.4 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Gelteq | 740.00 | -47,821.64 | - | 13.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.21 Mn |
| Jun 30, 2025 | 13.75 Mn |
| Dec 31, 2024 | 16.42 Mn |
| Jun 30, 2024 | 13.68 Mn |
| Jun 30, 2023 | 15.03 Mn |